January 2021
bwc20237

178
global pre filled syringes market
Global Pre-Filled
Syringes Market Size - Industry Trends & Outlook Report 2027
The Global Pre- Filled Syringes Market is anticipated to reach the valuation of approximately USD billion by the end of the year 2027, by expanding at a steady CAGR of % during the forecast period 2020- 2027. The pre-filled syringe market is expected to see growth in the forecast period. Due to the underlying fact that they are easy to apply, safe for both parties (doctors and patients), and accurate. Additionally, factors such as growing self-care practices among populations, tilt towards self-care devices, motivation for health awareness, etc. have helped in high demand for enhanced safety in syringes and injections therefore rising the demands.
Source: BlueWeave
Consulting
Global Pre-Filled
Syringes Market
The prefilled syringes are widely favored as they
aid in providing unit dose medication without any chances of errors and
misconduct. The rise of the prefilled syringes is there because of their
increasing applications or usages over the traditional processes. Where a
traditional process requires a skilled, medical practitioner here the same work
could get done by just any other able person, due to the ease prefilled
syringes or disposables provide. A prefilled injection or syringe is a single
dose pack of a vaccine, medication, etc. on which a needle has been attached by
the manufacturer. In earlier days, metal or glass syringes were heavily used,
but since the introduction of polymers, plastic and disposable syringes have
peaked. These plastic ones and disposable ones cannot be refilled or re-used,
making them medically absolutely safe. Moreover, innovations like parental
packaging and applications have made these devices easier to use for healthcare
professionals and patients themselves.
Global
Prefilled Syringes Market
Growth
Drivers
Ease
of availability, application, and better product delivery
Since the evolution of medical science
and pharmaceuticals, the major issue that still drives the market is the
feasibility, packaging, availability of any healthcare, pharmaceutical, and
medical and related products. And as the prefilled syringe is reliable,
convenient, and efficient for drug regulation. Also, it eradicates the tiring
task of drug transfer from vial to syringe then from syringe to patient.
Furthermore, the presence of accurate pre-measured quantity in the prefilled
syringe encourages patient compliance and in return is evident to reduce the
potential waste as well. The above-mentioned benefits of preloaded syringes
over normal ones will help in the prevalence of the market in the forecast
period.
Rise
in target disease’s population
The main application of prefilled
syringes is seen with respect to the treatment of chronic conditions, like
heart diseases, diabetes, and autoimmune diseases. These conditions are
required to be maintained constantly as they have no promising treatment. So as
a result, the prefilled syringes make the self-administration of medications
easy. There are some statistics to support the motion. Globally, in 2019 approx.
436 Million adults were suffering from diabetes, and it is expected to rise to
700 Million by 2045. And in a study carried out in the year 2017, by the
National Institute of Environmental Health Science, 24 Million people had
conditions relating to Autoimmune disease in the U.S., hence both the scenarios
create a larger base for the market in the upcoming forecast period.
Restraint
Scarcity
of prefilled syringes with safety characteristics
The prefilled syringes enable much greater patient safety by reducing and eliminating the potential for accidental needle sticks and exposure to toxicants that can occur while drawing medication from the medication vials. Although, a significant number of needle stick injuries are associated with the use of bare prefilled syringes as compared to the ones that have focused safety systems in them. As in the year 2019, approx. 500,000 injuries occur in the US annually, in which half of those (nearly 1,000 per day) occur in hospitals, even under medical supervision.
Impact of COVID-19 in the Industry
With the increasing Covid-19 infections
taking place globally, the alarming rates regarding the shortage of essential
life-saving devices and other essential medical supplies are persistent.
Moreover, till a pharmacological treatment is developed, ventilators act as a
vital treatment preference for the COVID-19 patients, who may require critical
care 24x7. The industry for the prefilled injections has been affected as
they’re getting more preference over the traditional ones; Because they allow
the taker to be at their house’s safe vicinity and not be at hospitals, medical
centers, where the chances of getting the virus are higher.
Global
Prefilled Syringe Market: Segmentation
On the basis of the product type or type,
the prefilled syringe market has two- Conventional and Safety. In which
Conventional has sub-categories which are Disposable and Reusable, the
disposable ones are more preferred over the disposable ones. Due to the fact
that they’re more hygienic, and safe to use in terms of spreading any given
disease. Also, the reusable ones are often unproportioned on the dosage (if
used by non-medical professional individuals), hence giving the prefilled
syringes one more advantage.
Based on the Material, we have plastic
and glass. In the early years, glass syringes were widely used. But as plastics
got introduced the market got shifted towards plastic syringes. Because of the
factors associated with it like, plastics being more break-resistant, easier to
handle, and easier to manufacture. And most importantly, the fact that plastics
are easier to acquire and are available throughout the year makes them more
susceptible to the expected market growth. Then we have segmentation based on
the design that is divided into Single chambered prefilled syringes, Dual
Chambered prefilled syringes, and Customized prefilled syringes. Lastly, the
classification is done based on Application which furthermore has division on
the disorders like Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology,
Thrombolytic, etc.
Global Prefilled
Syringe Market: Regional insights
Europe has held the highest share in the market,
in the year 2017, majorly since most of the key market players reside there.
With that the increasing awareness about safety injection/syringe technology.
Rising healthcare, expenditure, and the constantly growing demand for
biosimilars and biologics. Furthermore, the Asia Pacific region is anticipated
to grow with the most pace, due to increment in technological advancements and
injectable medicines, drugs, etc. All of this, for the treatment of growth in
the number of chronic and lifestyle-related, diseases in developing countries
such as India and China.
Source: BlueWeave Consulting
Recent Developments
·
04, Jan’ 2021- at Becton Dickinson, the
company recently invested
U.S.D. 1.2 billion to expand its pre-filled syringe capacity. And is
putting plans for opening a new plant in Europe, additionally upgrading to
six of the company’s existing sites in the U.S., Mexico, Europe and Japan.
Therefore, expecting to boost capacity by more than 50%, as per stated by their
spokesperson.
·
October’2020- at Baxter International Inc. (NYSE:
BAX), the company recognized the findings of a prospective, multicenter,
observational study on data from the OxirisNet Registry evaluating severely ill
patients with COVID-19 in Italy treated.
Competitive landscape
Key players in
the prefilled syringe market include- Becton Dickinson & Co., Gerresheimer,
Baxter International, Medtronic, SCHOTT AG, West Pharmaceuticals, Vetter
International, Unilife Corporation, Stevanato Group and Terumo Corporation, and
other prominent players.
Scope of
the Report
Attribute |
Details |
Years Considered |
Historical data
– 2016-2019 Base Year – 2020 Forecast – 2020–
2027 |
Facts Covered |
Revenue in USD
Billion |
Market Coverage |
U.S, Canada,
Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China,
India, Argentina, AUAE, South Africa, Saudi Arabia |
Product/Service Segmentation |
By Type, By Material, By Application,
By Region. |
Key Players |
Key players for
Prefill Syringe Market include Becton Dickinson & Co., Gerresheimer,
Baxter International, Medtronic, SCHOTT AG, West Pharmaceuticals, Vetter
International, Unilife Corporation, Stevanato Group, and Terumo Corporation
other prominent players. |
Scope of the Report
By Type
●
Conventional Pre Filled Syringe
ü Disposable prefilled
syringe
ü Usable prefilled
syringe
●
Safety Pre Filled Syringe
By Material
●
Glass
●
Plastic
By Design
●
Single Chambered Pre Filled Syringe
●
Double Chambered Pre Filled Syringe
●
Customized Pre Filled Syringe
By Application
●
Diabetes
●
Cancer
●
Arthritis
●
Ophthalmology
●
Thrombolytic
By Region
●
Asia Pacific
●
North America
●
Europe
●
Middle East & Africa
●
Latin America
We've been tracking the direct impact of COVID-19 on this market, and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Contact our sales team for more details at
Contact NowWHY CHOOSE US
-
24/7 Research support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Coustom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs.
-
Quality & Accuracy
offers best quality reports based on various authentic and accurate data findings.
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.